Financial results - BIOTEC SRL

Financial Summary - Biotec Srl
Unique identification code: 6346365
Registration number: J40/19497/1994
Nace: 4646
Sales - Ron
296.406
Net Profit - Ron
33.521
Employees
2
Open Account
Company Biotec Srl with Fiscal Code 6346365 recorded a turnover of 2024 of 296.406, with a net profit of 33.521 and having an average number of employees of 2. The company operates in the field of Comerţ cu ridicata al produselor farmaceutice și medicale having the NACE code 4646.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biotec Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 270.806 233.355 151.170 249.707 309.188 364.399 186.270 243.676 114.232 296.406
Total Income - EUR 271.892 233.611 151.363 249.755 312.879 364.842 186.901 244.601 114.376 299.659
Total Expenses - EUR 193.435 167.155 129.946 214.877 234.461 289.367 173.154 179.675 104.665 257.158
Gross Profit/Loss - EUR 78.458 66.456 21.417 34.878 78.418 75.474 13.747 64.927 9.711 42.501
Net Profit/Loss - EUR 66.160 55.577 19.905 32.454 75.269 71.941 11.883 62.488 8.556 33.521
Employees 2 2 2 2 2 0 0 2 2 2
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 160.9%, from 114.232 euro in the year 2023, to 296.406 euro in 2024. The Net Profit increased by 25.013 euro, from 8.556 euro in 2023, to 33.521 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biotec Srl

Rating financiar

Financial Rating -
BIOTEC SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biotec Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biotec Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biotec Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biotec Srl - CUI 6346365

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 7.993 10.850 7.193 4.906 14.239 10.314 8.167 8.956 4.868 23.362
Current Assets 222.424 245.449 118.455 140.717 151.858 198.566 160.029 145.868 240.182 431.233
Inventories 8.874 21.303 8.004 8.375 14.325 25.349 18.343 17.850 88.163 99.805
Receivables 90.547 107.723 34.624 94.568 49.054 85.376 81.508 76.070 129.787 310.227
Cash 123.004 116.422 75.827 37.774 88.480 87.841 60.177 51.948 22.232 21.201
Shareholders Funds 157.745 129.695 85.494 96.839 138.407 133.882 72.450 123.244 88.972 121.996
Social Capital 46 45 8.757 8.597 8.430 8.270 8.087 8.112 8.087 8.042
Debts 69.456 126.716 37.025 45.603 27.689 74.999 95.746 31.581 156.078 334.059
Income in Advance 3.330 3.296 3.240 3.180 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4646 - 4646"
CAEN Financial Year 4646
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 431.233 euro in 2024 which includes Inventories of 99.805 euro, Receivables of 310.227 euro and cash availability of 21.201 euro.
The company's Equity was valued at 121.996 euro, while total Liabilities amounted to 334.059 euro. Equity increased by 33.521 euro, from 88.972 euro in 2023, to 121.996 in 2024.

Risk Reports Prices

Reviews - Biotec Srl

Comments - Biotec Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.